Physician profile
Charuta Narayan Joshi
NPI 1609055771
$4,456.01
in general payments reported to CMS, 2019-2025
12 companies · $3,369 in 2025
The $3,369 reported for 2025 was more than what 83% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $349 · 2023: $172 · 2024: $567 · 2025: $3,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,225 · Food and Beverage: $572 · Travel and Lodging: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,225.00 |
| Food and Beverage | $572.02 |
| Travel and Lodging | $310.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $3,368.95 | 2025 | |
| Neuropace, INC. | $481.90 | 2024 | |
| Zogenix INC. | $348.68 | 2021 | |
| Ucb, INC. | $105.65 | 2023 | Fintepla |
| Biocodex, INC. | $84.74 | 2024 | |
| Sk Life Science, INC. | $66.09 | 2023 | Xcopri |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charuta Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.